South and Central America Warts Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Common Warts, Genital Warts, Flat Warts, and Others); Treatment (Physical Destruction, Immunomodulation, and Chemical Destruction); End User (Hospitals, Homecare, Specialty Clinics, and Others)

TIPRE00025057 | Pages: 124 | Pharmaceuticals | Sep 2021 | Type: Regional | Status: Published

Market Introduction

Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.

Thus, the new product developments are expected to create a significant demand for warts therapeutics in the coming years, which is further anticipated to drive the warts therapeutics market.

The COVID? 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South and Central America. It suffers from severe inequalities. With a vast population living in poverty, South and Central America continuously face widespread health problems due to overcrowding, limited sanitation, food insecurity, and unpredictable environmental conditions. Underfunded state?run hospitals are the only source of medical care in the region. Brazil is in a critical situation due to COVID-1. Lack of resources is creating more challenges in the region, hampering the growth of the market. All these factors will restrict the distribution and adoption of wart therapeutic products and services which will restrict the market growth. However, as the vaccination continues to these countries, the various market players in this region will again start focusing on development of wart therapeutics and increase their distribution of products. Hence impact of pandemic will become moderated on the wart therapeutics market.

 


Get more information on this report :



Market Overview and Dynamics

The Warts therapeutics market in South and Central America is expected to grow from US$ 113.6 million in 2021 to US$ 139.1 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2021 to 2028. Treatments of warts can be time-consuming and expensive; moreover, patients need to make multiple hospital visits to hospitals during treatment. All plantar warts treatments involve destroying the warts by freezing (cryosurgery), topical medications (chemosurgery), electrocautery (burning), and surgical excision, among others. Although these treatments are helpful, plantar warts have a high recurrence rate. Technological advancements are shaping warts treatments to overcome the shortcomings of the existing treatment procedures. Such innovations are likely to bring new trends in the warts therapeutical market in the coming years.

 

Key Market Segments

In terms of type, the common warts segment accounted for the largest share of the South and Central America warts therapeutics market in 2020. In terms of treatment, the physical destruction segment accounted for the largest share of the South and Central America warts therapeutics market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the South and Central America warts therapeutics market in 2020.

 

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the warts therapeutics market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bausch Health Companies Inc., Cipla Inc., Koninklijke Utermöhlen NV, Scholl's Wellness Company, Teva Pharmaceutical Industries Ltd, and GlaxoSmithKline plc.

 

Reasons to buy report

  • To understand the South and Central America Warts therapeutics market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for South and Central America Warts therapeutics market
  • Efficiently plan M&A and partnership deals in South and Central America Warts therapeutics market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South and Central America Warts therapeutics market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in South and Central America region.

 

SOUTH AND CENTRAL AMERICA WARTS THERAPEUTICS MARKET SEGMENTATION

 

By Type

  • Common Warts
  • Genital Warts
  • Flat Warts
  • Others

 

By Treatment

  • Physical Destruction
  • Cryotherapy
  • Surgical Removal
  • Laser Treatment
  • Immunomodulation
  • Interferons
  • Retinoids
  • Zinc
  • Chemical Destruction
  • Bleomycin
  • Cantharidin
  • Salicylic Acid
  • Others

 

By End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

 

By Country

  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America

 

Companies Mentioned

  1. Bausch Health Companies Inc.               
  2. Cipla Inc.                 
  3. Koninklijke Utermöhlen NV                 
  4. Scholl's Wellness Company             
  5. Teva Pharmaceutical Industries Ltd                  
  6. GlaxoSmithKline plc.          

 

 

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Warts Therapeutics Market – By Type

1.3.2          Warts Therapeutics Market – By Treatment

1.3.3          Warts Therapeutics Market – By End User

1.3.4          South and Central America Warts Therapeutics Market – By Country

2.           South and Central America Warts Therapeutics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           South and Central America Warts Therapeutics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Warts Therapeutics Market- South and Central America PEST Analysis

4.3          Expert Opinion

5.           South and Central America Warts Therapeutics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Rising Prevalence of Human Papillomavirus Infections and Recurrence of Genital Warts

5.1.2          New Product Developments

5.2          Market Restraints

5.2.1          Poor Diagnostics Scenario in Low-Income Countries

5.3          Market Opportunities

5.3.1          Increasing Awareness Regarding STIs

5.4          Future Trends

5.4.1          Emergence of New Technologies

5.5          Impact Analysis

6.           Warts Therapeutics Market – South and Central America Analysis

6.1          South and Central America Warts Therapeutics Market Revenue Forecasts and Analysis

7.           South and Central America Warts Therapeutics Market Analysis and Forecasts To 2028 – By Type

7.1          Overview

7.2          Warts Therapeutics Market Revenue Share, by Type (2020 and 2028)

7.3          Common Warts

7.3.1          Overview

7.3.2          Common Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Genital Warts

7.4.1          Overview

7.4.2          Genital Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Flat Warts

7.5.1          Overview

7.5.2          Flat Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Others

7.6.1          Overview

7.6.2          Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.           South and Central America Warts Therapeutics Market Analysis and Forecasts To 2028 – By Treatment

8.1          Overview

8.2          Warts Therapeutics Market Revenue Share, by Treatment (2020 and 2028)

8.3          Physical Destruction

8.3.1          Overview

8.3.2          Physical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1             Cryotherapy

8.3.2.2             Cryotherapy: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3             Surgical Removal

8.3.2.4             Surgical Removal: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.5             Laser Treatment

8.3.2.6             Laser Treatment: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Immunomodulation

8.4.1          Overview

8.4.2          Immunomodulation: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.4.2.1             Interferons

8.4.2.2             Interferons: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.4.2.3             Retinoids

8.4.2.4             Retinoids: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.4.2.5             Zinc

8.4.2.6             Zinc: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Chemical Destruction

8.5.1          Overview

8.5.2          Chemical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.5.2.1             Bleomycin

8.5.2.2             Bleomycin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.5.3          Cantharidin

8.5.3.1             Overview

8.5.3.2             Cantharidin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.5.3.3             Salicylic Acid

8.5.3.4             Salicylic Acid: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

8.5.3.5             Others

8.5.3.6             Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Warts Therapeutics Market Analysis – By End user

9.1          Overview

9.2          Warts Therapeutics Market Revenue Share, by End User (2020 and 2028)

9.3          Hospitals

9.3.1          Overview

9.3.2          Hospitals: Warts Hospitals Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Homecare

9.4.1          Overview

9.4.2          Homecare: Warts Homecare Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Specialty Clinics

9.5.1          Overview

9.5.2          Specialty Clinics: Warts Specialty Clinics Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Warts Therapeutics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1        South and Central America: Warts Therapeutics Market

10.1.1        Overview

10.1.2        South and Central America: Warts Therapeutics Market, by Country, 2021 & 2028 (%)

10.1.2.1          Brazil: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1           Brazil: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2           Brazil Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3           Brazil Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.1     Brazil Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.2     Brazil Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.3     Brazil Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4           Brazil Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2          Argentina: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1           Argentina: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2           Argentina Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3           Argentina Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.1     Argentina Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.2     Argentina Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.3     Argentina Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4           Argentina Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3          Rest of South and Central America: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1           Rest of South and Central America: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2           Rest of South and Central America Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3           Rest of South and Central America Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.1     Rest of South and Central America Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.2     Rest of South and Central America Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.3     Rest of South and Central America Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4           Rest of South and Central America Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on South and Central America Warts Therapeutics Market

11.1        South and Central America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.3        Organic Developments

12.3.1        Overview

12.4        Inorganic Developments

12.4.1        Overview

13.        COMPANY PROFILES

13.1        Bausch Health Companies Inc.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Cipla Inc.

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        Koninklijke Utermöhlen NV

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Scholl's Wellness Company

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        TEVA PHARMACEUTICAL INDUSTRIES LTD

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        GlaxoSmithKline plc.

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

 


LIST OF TABLES

Table 1.              Brazil Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              Brazil Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 3.              Brazil Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)

Table 4.              Brazil Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)

Table 5.              Brazil Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)

Table 6.              Brazil Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.              Argentina Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.              Argentina Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 9.              Argentina Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)

Table 10.            Argentina Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)

Table 11.            Argentina Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)

Table 12.            Argentina Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.            Rest of South and Central America Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 14.            Rest of South and Central America Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 15.            Rest of South and Central America Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)

Table 16.            Rest of South and Central America Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)

Table 17.            Rest of South and Central America Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)

Table 18.            Rest of South and Central America Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 19.            Organic Developments Done by Companies

Table 20.            Inorganic Developments Done by Companies

Table 21.            Glossary of Terms, Warts Therapeutics Market

 


LIST OF FIGURES

Figure 1.            Warts Therapeutics Market Segmentation

Figure 2.            South and Central America Warts Therapeutics Market Overview

Figure 3.            Common Warts Segment Held Largest Share Of Type In Warts Therapeutics Market

Figure 4.            Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Warts Therapeutics Market - South and Central America PEST Analysis

Figure 6.            Warts Therapeutics Market Impact Analysis of Driver and Restraints

Figure 7.            South and Central America Warts Therapeutics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Warts Therapeutics Market Revenue Share, by Type (2020 and 2028)

Figure 9.            Common Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          Genital Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Flat Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Warts Therapeutics Market Revenue Share, by Treatment (2020 and 2028)

Figure 14.          Physical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Cryotherapy: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Surgical Removal: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Laser Treatment: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.          Immunomodulation: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Interferons: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Retinoids: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Zinc: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Chemical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.          Bleomycin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.          Cantharidin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Salicylic Acid: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.          Warts Therapeutics Market Revenue Share, by End User (2020 and 2028)

Figure 28.          Hospitals: Warts Hospitals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.          Homecare: Warts Homecare Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.          Specialty Clinics: Warts Specialty Clinics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.          Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.          South and Central America: Warts Therapeutics Market, by Key Country – Revenue (2021) (USD Million)

Figure 33.          South and Central America: Warts Therapeutics Market, by Country, 2021 & 2028 (%)

Figure 34.          Brazil: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.          Argentina: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.          Rest of South and Central America: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.          Impact of COVID-19 Pandemic in South and Central America Country Markets

Figure 38.          Growth Strategies Done by the Companies in the Market, (%)

 

  1. Bausch Health Companies Inc.            
  2. Cipla Inc.                 
  3. Koninklijke Utermöhlen NV             
  4. Scholl's Wellness Company             
  5. Teva Pharmaceutical Industries Ltd             
  6. GlaxoSmithKline plc.      

               

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America warts therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America warts therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the warts therapeutics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000